Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carbios has demonstrated the ability to enzymatically recycle PET plastics—including colored and complex materials—into virgin-quality monomers at pilot scale. Its process can recycle up to ~250 kg/day as of recent reports and will scale to over 130 tons/day with its new facility. The company has produced branded bottles from recycled textile waste using its technology and collaborates with major consumer brands. No clinical results as it does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carbios.